Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation

Funakoshi-Tago, M; Yu, S; Kushida, A; Takeuchi, K; Tamura, H

Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharm, Div Hygien Chem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.

HELIYON, 2020; 6 (3):